![Rose Loughlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rose Loughlin
Corporate Officer/Principal chez
MODERNA, INC.
Profil
Rose Loughlin is currently Executive Vice President-Research at Moderna, Inc. since 2024.
Formerly, Dr. Loughlin was Head-Business Development at Biogen, Inc. from 2013 to 2015.
Education includes an undergraduate degree from Harvard University and a doctorate from the University of California.
Postes actifs de Rose Loughlin
| Sociétés | Poste | Début |
|---|---|---|
| MODERNA, INC. | Corporate Officer/Principal | 07/11/2024 |
Anciens postes connus de Rose Loughlin
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/12/2015 |
Formation de Rose Loughlin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
